Sumanta K. Pal , Petros Grivas , Shilpa Gupta , Nazli Dizman , Zeynep Zengin , Begona P. Valderrama , Alejo Rodriguez-Vida , Florian Roghmann , Elena Sevillano Fernandez , Surena F. Matin , Yohann Loriot , Srikala S. Sridhar , Guru Sonpavde , Mark T. Fleming , Seth P. Lerner , Joaquim Bellmunt , Viraj Master , Abhishek Tripathi , Kim Davis , David van Veenhuyzen , Siamak Daneshmand
{"title":"英夫拉替尼与安慰剂相比,可用于治疗带有 FGFR3 基因组变异的高风险已切除尿路上皮癌患者:PROOF302 3 期试验结果。","authors":"Sumanta K. Pal , Petros Grivas , Shilpa Gupta , Nazli Dizman , Zeynep Zengin , Begona P. Valderrama , Alejo Rodriguez-Vida , Florian Roghmann , Elena Sevillano Fernandez , Surena F. Matin , Yohann Loriot , Srikala S. Sridhar , Guru Sonpavde , Mark T. Fleming , Seth P. Lerner , Joaquim Bellmunt , Viraj Master , Abhishek Tripathi , Kim Davis , David van Veenhuyzen , Siamak Daneshmand","doi":"10.1016/j.eururo.2024.03.023","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 2","pages":"Pages 271-274"},"PeriodicalIF":25.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial\",\"authors\":\"Sumanta K. Pal , Petros Grivas , Shilpa Gupta , Nazli Dizman , Zeynep Zengin , Begona P. Valderrama , Alejo Rodriguez-Vida , Florian Roghmann , Elena Sevillano Fernandez , Surena F. Matin , Yohann Loriot , Srikala S. Sridhar , Guru Sonpavde , Mark T. Fleming , Seth P. Lerner , Joaquim Bellmunt , Viraj Master , Abhishek Tripathi , Kim Davis , David van Veenhuyzen , Siamak Daneshmand\",\"doi\":\"10.1016/j.eururo.2024.03.023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12223,\"journal\":{\"name\":\"European urology\",\"volume\":\"87 2\",\"pages\":\"Pages 271-274\"},\"PeriodicalIF\":25.3000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0302283824022474\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0302283824022474","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial
期刊介绍:
European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.